Clinical Trials Directory

Trials / Completed

CompletedNCT03879408

Naproxen Sodium/Acetaminophen Proof of Concept Dosing Study

Randomized, Double-Blind, Placebo And Active Controlled, Study To Evaluate Two Strengths Of Concomitantly Dosed Naproxen Sodium With Acetaminophen, Compared With Naproxen Sodium and Hydrocodone/Acetaminophen In Postoperative Dental Pain

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
290 (actual)
Sponsor
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division · Industry
Sex
All
Age
17 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Study assessing efficacy and safety of concomitantly dosed naproxen sodium with acetaminophen, compared with naproxen sodium, hydrocodone/acetaminophen and Placebo in a postoperative dental pain.

Detailed description

This is a randomized, double-blind, placebo- and active-controlled, parallel-group study to evaluate the analgesic efficacy and safety of concomitantly administered naproxen sodium 440 mg with acetaminophen 1000 mg and concomitantly administered naproxen sodium 220 mg with acetaminophen 650 mg, compared with a fixed combination of hydrocodone 10 mg/acetaminophen 650 mg, naproxen sodium 440 mg, and placebo over a twelve-hour period after surgical extraction of four third molars.

Conditions

Interventions

TypeNameDescription
DRUG440 mg naproxen sodium with 1000 mg acetaminophen440 mg naproxen sodium with 1000 mg acetaminophen administered as a single dose of two naproxen sodium 220 mg tablets and two acetaminophen 500 mg tablets
DRUG220 mg naproxen sodium with 650 mg acetaminophen220 mg naproxen sodium with 650 mg acetaminophen administered as a single dose of one naproxen sodium 220 mg tablet and two acetaminophen 325 mg tablets and one placebo tablet
DRUG10 mg hydrocodone + 650 mg acetaminophen10 mg hydrocodone with 650 mg acetaminophen administered as a single dose of two hydrocodone 5 mg + acetaminophen 325 mg tablets and two placebo tablets
DRUG440 mg naproxen sodium440 mg naproxen sodium administered as a single dose of two naproxen sodium 220 mg tablets and two placebo tablets
DRUGPlacebo tabletSingle dose of four placebo tablets

Timeline

Start date
2019-05-28
Primary completion
2019-11-07
Completion
2019-11-13
First posted
2019-03-18
Last updated
2022-12-05
Results posted
2022-12-05

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03879408. Inclusion in this directory is not an endorsement.